Position in INVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,928,646
+$786,758 QoQ
Shares Held
125,693
+17.3% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 55.12876612062724.ToString("F0")%
Shared 0.ToString("F0")%
None 44.87123387937276.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARTINGALE ASSET MANAGEMENT L P holds $113,335,067 across 56 Biotechnology names. INVA ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44,750 | $19,982,665 | |
| 2 | INCY |
Incyte Corp
|
164,646 | $15,496,481 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,861 | $13,027,483 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
46,721 | $8,832,605 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,762 | $3,546,183 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
139,535 | $3,454,886 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,114 | $3,346,419 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
139,964 | $3,115,598 |
All Filings in INVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,928,646 | 125,693 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,141,888 | 107,148 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,449,305 | 79,414 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,593,397 | 79,313 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,421,608 | 78,412 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,350,558 | 77,842 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,503,128 | 77,842 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,267,588 | 77,292 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,177,929 | 77,292 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,217,307 | 75,892 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $985,836 | 75,892 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $966,703 | 75,939 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $831,802 | 73,938 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $942,287 | 71,116 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $801,774 | 69,059 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,404,842 | 95,179 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,841,984 | 95,193 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,184,057 | 68,641 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $894,803 | 53,549 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $160,236 | 11,949 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $286,816 | 23,149 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $696,482 | 66,649 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,721,623 | 123,149 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,448,302 | 123,155 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||